Correction: Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics (Blood Cancer Journal, (2023), 13, 1, (57), 10.1038/s41408-023-00830-w)

Bing Z. Carter; Po Yee Mak; Wenjing Tao; Edward Ayoub; Lauren B. Ostermann; Xuelin Huang; Sanam Loghavi; Steffen Boettcher; Yuki Nishida; Vivian Ruvolo; Paul E. Hughes; Phuong K. Morrow; Torsten Haferlach; Steven Kornblau; Muharrem Muftuoglu; Michael Andreeff

doi:10.1038/s41408-023-00857-z

Correction: Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics (Blood Cancer Journal, (2023), 13, 1, (57), 10.1038/s41408-023-00830-w)

Bing Z. Carter
, Po Yee Mak
, Wenjing Tao
, Edward Ayoub
, Lauren B. Ostermann
, Xuelin Huang
, Sanam Loghavi
, Steffen Boettcher
, Yuki Nishida
, Vivian Ruvolo
, Paul E. Hughes
, Phuong K. Morrow
, Torsten Haferlach
, Steven Kornblau
, Muharrem Muftuoglu
, Michael Andreeff

Research output: Contribution to journal › Comment/debate

Abstract

The following acknowledgement was missing from this article. EA is a TRIUMPH Fellow in the CPRIT Training Program (RP210028). The original article has been corrected.

Original language	English
Article number	80
Journal	Blood Cancer Journal
Volume	13
Issue number	1
DOIs	https://doi.org/10.1038/s41408-023-00857-z
State	Published - Dec 2023
Externally published	Yes

Access to Document

10.1038/s41408-023-00857-z

Fingerprint

Dive into the research topics of 'Correction: Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics (Blood Cancer Journal, (2023), 13, 1, (57), 10.1038/s41408-023-00830-w)'. Together they form a unique fingerprint.

Cite this

Carter, B. Z., Mak, P. Y., Tao, W., Ayoub, E., Ostermann, L. B., Huang, X., Loghavi, S., Boettcher, S., Nishida, Y., Ruvolo, V., Hughes, P. E., Morrow, P. K., Haferlach, T., Kornblau, S., Muftuoglu, M., & Andreeff, M. (2023). Correction: Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics (Blood Cancer Journal, (2023), 13, 1, (57), 10.1038/s41408-023-00830-w). Blood Cancer Journal, 13(1), Article 80. https://doi.org/10.1038/s41408-023-00857-z

@article{d4b17e0ddd99485eae7565df4751a45e,

title = "Correction: Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics (Blood Cancer Journal, (2023), 13, 1, (57), 10.1038/s41408-023-00830-w)",

abstract = "The following acknowledgement was missing from this article. EA is a TRIUMPH Fellow in the CPRIT Training Program (RP210028). The original article has been corrected.",

author = "Carter, \{Bing Z.\} and Mak, \{Po Yee\} and Wenjing Tao and Edward Ayoub and Ostermann, \{Lauren B.\} and Xuelin Huang and Sanam Loghavi and Steffen Boettcher and Yuki Nishida and Vivian Ruvolo and Hughes, \{Paul E.\} and Morrow, \{Phuong K.\} and Torsten Haferlach and Steven Kornblau and Muharrem Muftuoglu and Michael Andreeff",

note = "Publisher Copyright: {\textcopyright} 2023, The Author(s).",

year = "2023",

month = dec,

doi = "10.1038/s41408-023-00857-z",

language = "English",

volume = "13",

journal = "Blood Cancer Journal",

issn = "2044-5385",

publisher = "Springer Nature",

number = "1",

}

Carter, BZ, Mak, PY, Tao, W, Ayoub, E, Ostermann, LB, Huang, X, Loghavi, S, Boettcher, S, Nishida, Y, Ruvolo, V, Hughes, PE, Morrow, PK, Haferlach, T, Kornblau, S, Muftuoglu, M & Andreeff, M 2023, 'Correction: Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics (Blood Cancer Journal, (2023), 13, 1, (57), 10.1038/s41408-023-00830-w)', Blood Cancer Journal, vol. 13, no. 1, 80. https://doi.org/10.1038/s41408-023-00857-z

Correction: Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics (Blood Cancer Journal, (2023), 13, 1, (57), 10.1038/s41408-023-00830-w). / Carter, Bing Z.; Mak, Po Yee; Tao, Wenjing et al.
In: Blood Cancer Journal, Vol. 13, No. 1, 80, 12.2023.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction

T2 - Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics (Blood Cancer Journal, (2023), 13, 1, (57), 10.1038/s41408-023-00830-w)

AU - Carter, Bing Z.

AU - Mak, Po Yee

AU - Tao, Wenjing

AU - Ayoub, Edward

AU - Ostermann, Lauren B.

AU - Huang, Xuelin

AU - Loghavi, Sanam

AU - Boettcher, Steffen

AU - Nishida, Yuki

AU - Ruvolo, Vivian

AU - Hughes, Paul E.

AU - Morrow, Phuong K.

AU - Haferlach, Torsten

AU - Kornblau, Steven

AU - Muftuoglu, Muharrem

AU - Andreeff, Michael

PY - 2023/12

Y1 - 2023/12

N2 - The following acknowledgement was missing from this article. EA is a TRIUMPH Fellow in the CPRIT Training Program (RP210028). The original article has been corrected.

AB - The following acknowledgement was missing from this article. EA is a TRIUMPH Fellow in the CPRIT Training Program (RP210028). The original article has been corrected.

UR - https://www.scopus.com/pages/publications/85159495067

U2 - 10.1038/s41408-023-00857-z

DO - 10.1038/s41408-023-00857-z

M3 - Comment/debate

C2 - 37193700

AN - SCOPUS:85159495067

SN - 2044-5385

VL - 13

JO - Blood Cancer Journal

JF - Blood Cancer Journal

IS - 1

M1 - 80

ER -

Carter BZ, Mak PY, Tao W, Ayoub E, Ostermann LB, Huang X et al. Correction: Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics (Blood Cancer Journal, (2023), 13, 1, (57), 10.1038/s41408-023-00830-w). Blood Cancer Journal. 2023 Dec;13(1):80. doi: 10.1038/s41408-023-00857-z